Richard C. Malabre

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Carolyn M. Rucci, attorney-in-fact for Richard C. Malabre
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard C. Malabre:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akebia Therapeutics, Inc. SVP, Chief Accounting Officer Common Stock 299,390 $416,152 $1.39 02 Feb 2026 Direct
Akebia Therapeutics, Inc. SVP, Chief Accounting Officer Stock Option (Right to buy) 119,000 30 Jan 2026 Direct

Insider Reports Filed by Richard C. Malabre

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKBA Akebia Therapeutics, Inc. 02 Feb 2026 2 -$68,838 4 SVP, Chief Accounting Officer 04 Feb 2026, 16:15
AKBA Akebia Therapeutics, Inc. 30 Jan 2026 2 $0 4 SVP, Chief Accounting Officer 03 Feb 2026, 16:37
AKBA Akebia Therapeutics, Inc. 09 Jun 2025 3 -$34,950 4 SVP, Chief Accounting Officer 11 Jun 2025, 17:13
AKBA Akebia Therapeutics, Inc. 04 Jun 2025 1 -$47,069 4 SVP, Chief Accounting Officer 05 Jun 2025, 16:35
AKBA Akebia Therapeutics, Inc. 31 Jan 2025 3 -$63,424 4 SVP, Chief Accounting Officer 04 Feb 2025, 17:52
AKBA Akebia Therapeutics, Inc. 31 Jan 2024 2 $0 4 Chief Accounting Officer 02 Feb 2024, 16:11
AKBA Akebia Therapeutics, Inc. 08 Jan 2024 0 $0 3 Chief Accounting Officer 18 Jan 2024, 16:21